patent/CN-104530012-A

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_159936a9a847e1b85fb4d921ae15d764
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
filingDate	2015-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bcb4ce2c07706533757f51b0f91eaf8
publicationDate	2015-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-104530012-A
titleOfInvention	Amantadine tetrazole derivatives, preparation method and use thereof
abstract	The invention relates to the field of medicine related to diabetes. Specifically, the present invention relates to dipeptidyl peptidase-IV inhibitors having a general formula I containing an amantadine tetrazole structure, a preparation method thereof, and their application in the preparation of diabetes medicines. Wherein, R 1 is selected from H, C1-C5 alkyl, C3-C5 cycloalkyl.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111423396-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111423396-B
priorityDate	2015-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2318007-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006012441-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468147168

Total number of triples: 18.